IC
BLU

Ikarian Capital’s BELLUS Health Inc. BLU Stock Holding History

Ikarian Capital’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-85,200
Closed -$900K – 118
2022
Q3 		$900K Sell
85,200
-14,800
-15% -$157K 0.18% 71
2022
Q2 		$924K Buy
+100,000
New +$818K 0.17% 80

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Ikarian Capital's BLU Position: Q2 2023 in Review

Ikarian Capital sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 885,334 shares — an estimated $6.37M sold.

Ikarian Capital first reported a position in BLU in Q4 2019 and held it in 13 quarters. The position peaked at $9.41M in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Ikarian Capital reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Ikarian Capital sold 885,334 BELLUS Health Inc. shares in Q2 2023, an estimated $6.37M.
  • Ikarian Capital first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 13 quarters.
  • Ikarian Capital's BELLUS Health Inc. position peaked at $9.41M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Ikarian Capital's 13F filing for Q2 2023, filed 14 Aug 2023.